ไทย
简体中文
Don’t Underestimate RSV in Adults and Seniors
Respiratory syncytial virus (RSV) is a highly contagious respiratory illness that typically affects infants and children, but it can be very serious for older adults. RSV can lead to pneumonia, hospitalization, and even death.
- What is RSV and Symptoms of RSV?
- Severe health risk from RSV in senior adults.
- RSV vaccine for Adults
Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that typically affects infants and young children. However, RSV can also pose a significant health threat to adults, especially senior adults and those living in the same household. While often presenting with mild cold-like symptoms, RSV can lead to pneumonia, hospitalization, and even death in vulnerable populations.
With recent advances in medical, RSV vaccines have been developed for adults, marking a significant step in preventive healthcare.
Here’s a comprehensive look at RSV in adults, including its causes, symptoms, diagnosis, treatment, and the promising role of a new vaccine.
What is RSV?
RSV is a highly contagious respiratory virus belonging to the same family as the common cold virus. It spreads easily through respiratory droplets expelled when coughing, sneezing, talking, or close contact with infected person. It can also be transmitted through contact with contaminated surfaces.
SYMPTOMS of RSV in Adults
Adults infected with RSV may experience symptoms similar to the common cold, including:
- Congestion, runny or stuffy nose
- Cough (may become productive with mucus)
- Sore throat
- Headache
- Fever
- Fatigue
- Wheezing (in some cases)
Who is at HIGH RISK for RSV?
Studies suggest a significant portion of the adult population is infected with RSV annually, though most experience mild illness. However, for some adults, RSV infection can lead to more severe complications, particularly for:
- Adults aged 60 years and over.
- Adults aged 18–59 years with chronic underlying conditions (such as pulmonary disease, asthma, heart disease, diabetes, chronic kidney disease, or chronic liver disease).
Severe Cases in Senior Adults:
The risk of severe complications increases with age. Adults over 60 and those with underlying health conditions such as chronic heart or lung diseases are especially vulnerable to RSV complications. This group is particularly vulnerable due to the natural decline in immune system efficiency with age.
In seniors, RSV infection can progress to:
- Pneumonia: Inflammation of the lungs
- Bronchitis: Inflammation of the airways in the lungs
- Dehydration: Due to difficulty with fluids and increased respiratory effort
- Worsening of pre-existing conditions like heart disease, COPD, or asthma
These complications can lead to hospitalization and even death.
According to the Centers for Disease Control and Prevention (CDC), RSV is estimated to contribute to:
- Infection and Hospitalization Rates : RSV is responsible for approximately 60,000 to 160,000 hospitalizations annually among older adults in the United States alone. Estimates suggest RSV contributes to a significant portion (up to 10%) of hospitalizations in adults aged 65 and over.
- Mortality Rate: 6,000 to 10,000 deaths among adults aged 65 and older in the United States annually.
DIAGNOSIS of RSV in Adults
Diagnosing RSV in adults can be challenging because symptoms often mimic those of other respiratory illnesses. Doctors usually rely on a combination of:
- Medical history: Physician will inquire about symptoms and potential risk factors.
- Physical examination: Listening to the lungs for abnormal sounds.
- Rapid RSV test: A nasal swab test to detect the virus directly.
TREATMENT
There is no specific treatment for RSV. In most cases, Treatment focuses on managing symptoms and preventing complications. This may include:
- Over-the-counter medications: Pain relievers (like acetaminophen or ibuprofen) and cough suppressants may help manage discomfort.
- Hydration: Drink plenty of fluids to prevent dehydration.
- Rest: Allow the body to recover.
- In severe cases, hospitalization and oxygen therapy or antiviral medication may be required.
RSV VACCINE FOR ADULTS
The good news is there’s a new effective way in the fight against RSV in senior adults: The RSV Vaccines
AREXVY (developed by GSK) is a recombinant protein vaccine that help the body develop immunity to RSV. This vaccine is particularly effective. It has shown an efficacy rate of
- 82.6% in preventing lower respiratory tract diseases caused by RSV in clinical trials.
- 94.6% efficacy in preventing these conditions in older adults with chronic medical issues.
RSV vaccine is recommended for:
- Adults aged 60 years and over.
- Adults aged 18–59 years with chronic underlying conditions (such as pulmonary disease, asthma, heart disease, diabetes, chronic kidney disease, or chronic liver disease).
Dosage
Arexvy is administered as a single intramuscular injection in the upper arm.
EFFECTIVENESS of RSV VACCINES
Studies have shown promising results regarding the effectiveness of these vaccines:
- Reducing the risk of lower respiratory tract infections (LRTI) caused by RSV by 80-90% in the first RSV season after vaccination and remains protective for at least two seasons.
- Reduction in Hospitalization: Research suggests vaccine can significantly reduce the risk of RSV hospitalization by up to 80% during the first RSV season after vaccination and remains moderately effective (around 50%) in the second season.
- Overall Protection: Both vaccines offer some protection against RSV infection and its complications, reducing the severity of symptoms even if a breakthrough infection occurs.
Why Should Elderly Get Vaccinated?
Getting vaccinated against RSV offers several benefits for adults, especially seniors:
- Reduces the risk of severe respiratory illness.
- Milder symptoms if infected
- Decreases the likelihood of hospitalization and death.
- Helps maintain quality of life by preventing disease complications.
- Protection of vulnerable populations through herd immunity
Here are some key things to remember about the RSV vaccine for adults:
- The vaccine is most effective when administered before the RSV season typically begins in rainy season in topical country or in fall in Europe and USA.
- Like all vaccines, RSV vaccines may cause mild side effects like pain, redness, or swelling at the injection site.
Conclusion:
RSV can be a serious concern for adults, particularly seniors. While it may seem like a common cold, it’s important to be aware of the potential risks and complications. Vaccination offers a safe and effective way for adults 60 and older or adults with chronic disease or weaken immune to protect themselves from the potentially life-threatening consequences of RSV. By taking preventive measures and seeking timely care if needed, you can minimize the impact of RSV and protect your health the the health of your loved ones.
